Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
This information is for educational purposes only
(2015, European Neuropsychopharmacology ) investigated neural and cognitive processing changes following ARA-290 administration in human volunteers, examining its CNS modulatory properties Metabolic and Tissue Repair Research: Type 2 diabetes metabolic control Phase 2 study (Brines M et al., 2014) confirmed improvement in HbA1c and lipid profiles, with effects persisting throughout a 56-day observation period Pancreatic islet protection pre-clinical research has examined ARA-290 for cytoprotection of pancreatic islet cells via EPO/IRR anti-apoptotic signalling, relevant to both T1DM and T2DM research Wound healing and burn models pre-clinical studies confirmed ARA-290 promotes vascular repair and improved relative vascular area (RVA) in burn wound models via IRR-mediated angiogenic signalling Acute kidney injury models confirmed beneficial effects in AKI pre-clinical models via IRR anti-apoptotic and anti-inflammatory pathways Pulmonary and sarcoidosis models beyond neuropathy, ARA-290 has been studied in sarcoidosis systemic inflammation models, examining IRRs role in multi-system inflammatory disease modulation What Do Studies Say About ARA-290 Peptide
Compounds such as CJC-1295, Ipamorelin, Sermorelin, and IGF-1 are frequently used to support recovery, body composition, sleep quality, and healthy aging
It can be adapted to different needs, whether you are addressing ongoing concerns or looking to support your body proactively
These molecules may offer novel mechanisms of action that are less likely to promote resistance development
Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells
US$ 29.42
US$ 28.68
US$ 27.56
US$ 29.04
US$ 21.68
US$ 21.00
US$ 28.86
US$ 26.06